The Latest Breaking News from Vaccine

Moderna, Inc. (NASDAQ:MRNA) revealed topline results on Wednesday from a Phase 3 trial evaluating the efficacy of mRNA-1647, the company’s investigational cytomegalovirus (CMV) vaccine. CMV is a herpes virus. Those who are pregnant or have compromised immune systems are most at risk from CMV.

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we and our colleagues published in the journal Nature.

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors

Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did not get the vaccine.

Researchers now want to conduct larger studies to confirm the findings.

Moderna’s story is far from over, but it needs patience and successful execution.

More than 420 anti-science bills attacking longstanding public health protections – vaccines, milk safety, and fluoride – have been introduced in statehouses across the U.S. this year, part of an organized, politically savvy campaign to enshrine a conspiracy theory-driven agenda into law

More than 420 anti-science bills attacking longstanding public health protections – vaccines, milk safety and fluoride – have been introduced in statehouses across the U.S. this year

Discovery could be ‘significant step’ towards universal cancer vaccine

Unrelated cases mark first time clade I of disease formerly known as monkeypox has spread within US, officials say

Polling finds majority consider £1bn funding for Aids, TB and malaria vaccines a UK success story